Soleiman applies decades of clinical decision-making to laboratory interpretation, side-effect management, and riskbenefit counseling for GLP1based therapies
Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides
[00:32:20] Emily Field: For someone who has struggled with appetite regulation for years, that shift can feel incredibly freeing
WHN wants you to know the facts in deciding whether these GLP-1 weight loss drugs are a good choice for you or your family
One of the advanced options we offer is GLP-1 treatment, a breakthrough in the field of medical weight loss
Clinical trials show tirzepatide produces 22.5% average weight loss compared to semaglutides 14.9%, likely because activating both incretin pathways provides more comprehensive metabolic regulation than activating one pathway alone